U Halbreich

Summary

Affiliation: University at Buffalo
Country: USA

Publications

  1. ncbi Culturally-sensitive complaints of depressions and anxieties in women
    Uriel Halbreich
    Biobehavior Research, SUNY University at Buffalo, NY 14214, USA
    J Affect Disord 102:159-76. 2007
  2. ncbi The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions--the need for interdisciplinary integration
    Uriel Halbreich
    Biobehavior Program, State University of New York at Buffalo, NY 14214, USA
    Am J Obstet Gynecol 193:1312-22. 2005
  3. ncbi Premenstrual syndromes: closing the 20th century chapters
    U Halbreich
    Biobehavioral Research, State University of New York at Buffalo, 14215, USA
    Curr Opin Obstet Gynecol 11:265-70. 1999
  4. ncbi The fountain of mental youth. Search for homeostatic and adaptational hormonal processes
    Uriel Halbreich
    School of Medicine and Biomedical Sciences, Biobehavioral Program, SUNY at Buffalo, 14214 3016, USA
    Psychoneuroendocrinology 29:697-704. 2004
  5. ncbi Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and research
    Uriel Halbreich
    Biobehavioral Research Program, State University of New York at Buffalo, Hayes Annex C, Suite 1, 3435 Main Street, Buffalo, NY 14214, USA
    CNS Spectr 9:177-84. 2004
  6. ncbi Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline
    Uriel Halbreich
    Biobehavioural Program, School of Medicine and Biomedical Sciences, Hayes C, Suite 1, 3435 Main St, Building 5, Buffalo, NY 14214 3016, USA
    Expert Opin Pharmacother 4:2065-78. 2003
  7. ncbi The etiology, biology, and evolving pathology of premenstrual syndromes
    Uriel Halbreich
    Biobehavioral Program, School of Medicine and Biomedical Sciences, Buffalo, NY 14214 3016, USA
    Psychoneuroendocrinology 28:55-99. 2003
  8. ncbi The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
    Uriel Halbreich
    Department of Psychiatry, State University of New York at Buffalo, Buffalo, NY, USA
    Psychoneuroendocrinology 28:1-23. 2003
  9. ncbi Hormonal aspects of schizophrenias: an overview
    U Halbreich
    Biobehavioral Program, School of Medicine and Biomedical Sciences, Hayes C, Suite 1, 3435 Main St, Building 5, Buffalo, NY 14214 3016, USA
    Psychoneuroendocrinology 28:1-16. 2003
  10. ncbi Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects
    U Halbreich
    Biobehavioral Program, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Hayes C Ste 1, 3435 Main St, Building 5, Buffalo, NY 14214 3016, USA
    Psychoneuroendocrinology 28:53-67. 2003

Detail Information

Publications46

  1. ncbi Culturally-sensitive complaints of depressions and anxieties in women
    Uriel Halbreich
    Biobehavior Research, SUNY University at Buffalo, NY 14214, USA
    J Affect Disord 102:159-76. 2007
    ..quot;Cross-cultural sensitivity" emphasizes culturally-appropriate translations of symptoms and questions, assuming that concepts and constructs are applicable...
  2. ncbi The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions--the need for interdisciplinary integration
    Uriel Halbreich
    Biobehavior Program, State University of New York at Buffalo, NY 14214, USA
    Am J Obstet Gynecol 193:1312-22. 2005
    ..An interdisciplinary approach is needed for better understanding of developmental processes and the development of measurements and interventions to prevent long-term impact on the offspring...
  3. ncbi Premenstrual syndromes: closing the 20th century chapters
    U Halbreich
    Biobehavioral Research, State University of New York at Buffalo, 14215, USA
    Curr Opin Obstet Gynecol 11:265-70. 1999
    ....
  4. ncbi The fountain of mental youth. Search for homeostatic and adaptational hormonal processes
    Uriel Halbreich
    School of Medicine and Biomedical Sciences, Biobehavioral Program, SUNY at Buffalo, 14214 3016, USA
    Psychoneuroendocrinology 29:697-704. 2004
    ..Their elucidation would substantially contribute to understanding of well-being, disorders, and successful as well as unsuccessful aging...
  5. ncbi Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and research
    Uriel Halbreich
    Biobehavioral Research Program, State University of New York at Buffalo, Hayes Annex C, Suite 1, 3435 Main Street, Buffalo, NY 14214, USA
    CNS Spectr 9:177-84. 2004
    ..Clarification of the nature and phenotyping of mental and general symptoms during pregnancy is an important step for the development of effective interventions...
  6. ncbi Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline
    Uriel Halbreich
    Biobehavioural Program, School of Medicine and Biomedical Sciences, Hayes C, Suite 1, 3435 Main St, Building 5, Buffalo, NY 14214 3016, USA
    Expert Opin Pharmacother 4:2065-78. 2003
    ....
  7. ncbi The etiology, biology, and evolving pathology of premenstrual syndromes
    Uriel Halbreich
    Biobehavioral Program, School of Medicine and Biomedical Sciences, Buffalo, NY 14214 3016, USA
    Psychoneuroendocrinology 28:55-99. 2003
    ....
  8. ncbi The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
    Uriel Halbreich
    Department of Psychiatry, State University of New York at Buffalo, Buffalo, NY, USA
    Psychoneuroendocrinology 28:1-23. 2003
    ..Appropriate recognition of the disorder and its impact should lead to treatment of more women with PMS/PMDD. Efficacious treatments are available. They should reduce individual suffering and impact on family, society, and economy...
  9. ncbi Hormonal aspects of schizophrenias: an overview
    U Halbreich
    Biobehavioral Program, School of Medicine and Biomedical Sciences, Hayes C, Suite 1, 3435 Main St, Building 5, Buffalo, NY 14214 3016, USA
    Psychoneuroendocrinology 28:1-16. 2003
    ..Diabetes, dyslipidemia, and decreased bone mineral density, as well as some other adverse effects are more 'silent' but their long-term effects are detrimental. 'Hormone-friendlier' interventions might be needed...
  10. ncbi Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects
    U Halbreich
    Biobehavioral Program, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Hayes C Ste 1, 3435 Main St, Building 5, Buffalo, NY 14214 3016, USA
    Psychoneuroendocrinology 28:53-67. 2003
    ..Antipsychotic-induced hyperprolactinemia may be associated with similar clinical manifestations; these are examined with particular reference to patients with schizophrenia...
  11. ncbi Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder
    Uriel Halbreich
    State University of New York at Buffalo School of Medicine, 14215, USA
    Obstet Gynecol 100:1219-29. 2002
    ..The goal of the current study was to evaluate the efficacy and tolerability of sertraline for premenstrual dysphoric disorder when treatment was limited to the luteal phase...
  12. ncbi The pathophysiologic background for current treatments of premenstrual syndromes
    Uriel Halbreich
    Biobehavioral Program, State University of New York SUNY at Buffalo, Clinical Center, 462 Grider Street, Buffalo, NY 14215, USA
    Curr Psychiatry Rep 4:429-34. 2002
    ..Environmental inputs to pathophysiology, which are not discussed here, have been addressed by attempts at changes of lifestyle, coping style, and environment...
  13. ncbi Selective oestrogen receptor modulators--current and future brain and behaviour applications
    U Halbreich
    School of Medicine and Biomedical Sciences, SUNY Clinical Center, Room BB170, 462 Grider Street, Buffalo, NY 14215, USA
    Expert Opin Pharmacother 1:1385-98. 2000
    ..It is quite safe to predict that the recent accumulation of knowledge, combined with the large, thirsty anticipated market for these 'designer oestrogens', will lead to clinical trials of CNS-targeted SERMs in the very near future...
  14. ncbi Are women with premenstrual dysphoric disorder prone to osteoporosis?
    U Halbreich
    Biobehavioral Program, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, 14215, USA
    Psychosom Med 63:361-4. 2001
    ..The objective of this study was to examine whether bone mineral density (BMD) is reduced in women with premenstrual dysphoric disorder (PMDD)...
  15. ncbi Role of estrogen in the aetiology and treatment of mood disorders
    U Halbreich
    Biobehavioral Program, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA
    CNS Drugs 15:797-817. 2001
    ..It is still unclear whether estrogen is efficacious as an adjunct to selective serotonin reuptake inhibitors or as one of the paradigms to manage treatment-resistance depression in menopausal women, but such efficacy is plausible...
  16. ncbi The second-generation 'atypical' antipsychotics: similar improved efficacy but different neuroendocrine side effects
    R Tandon
    University of Michigan Hospital, 1500 E Medical Center Drive, Department of Psychiatry, UH9C 9150, Ann Arbor, MI 48109 0120, USA
    Psychoneuroendocrinology 28:1-7. 2003
    ..A critical overview of neuroendocrine abnormalities in schizophrenia is provided and the differential impact of different antipsychotics in contributing to neuroendocrine dysfunction is discussed...
  17. ncbi Oral contraceptives and mood
    L S Kahn
    School of Medicine and Biomedical Sciences, SUNY Clinical Center, Buffalo 14215, USA
    Expert Opin Pharmacother 2:1367-82. 2001
    ..There is a great need for more longitudinal, randomised, placebo-controlled studies to further clarify the mood and behavioural effects of OCs...
  18. ncbi The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder--clinical procedures and research perspectives
    U Halbreich
    Biobehavioral Program, State University of New York at Buffalo, Buffalo, New York 14214-3016, USA
    Gynecol Endocrinol 19:320-34. 2004
    ..The gaps of knowledge in the description and diagnosis of PMS are described, with suggestions for future directions for research...
  19. ncbi Effectiveness of St John's wort in major depression: a randomized controlled trial
    R C Shelton
    Department of Psychiatry, Vanderbilt University, Nashville Tennessee, USA
    JAMA 285:1978-86. 2001
    ..Extracts of St John's wort are widely used to treat depression. Although more than 2 dozen clinical trials have been conducted with St John's wort, most have significant flaws in design and do not enable meaningful interpretation...
  20. ncbi Effects of electroacupuncture and fluoxetine on the density of GTP-binding-proteins in platelet membrane in patients with major depressive disorder
    Yuqing Song
    Institute of Mental Health, Peking University, China
    J Affect Disord 98:253-7. 2007
    ..Thus, the objective of this study is to investigate the therapeutic effect of EA on GTP-binding-protein (G protein) in platelet membrane using fluoxetine as a comparison...
  21. ncbi Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?
    Uriel Halbreich
    Biobehavior Program, Department of Psychiatry, State University of New York at Buffalo, New York 14214, USA
    CNS Drugs 20:523-47. 2006
    ..Such information would also improve understanding of the putative pathophysiological mechanisms underlying PMS and PMDD, and may point to a more specific diagnosis of these conditions...
  22. ncbi Screening of patients for clinical trials of premenstrual syndrome/premenstrual dysphoric disorder: methodological issues
    Judith T Halbreich
    Clinical Trials Biobehavioral Program, State University of New York at Buffalo, Hayes Annex C, 3435 Main Street, Buffalo, NY 14214, USA
    Psychiatry Res 141:349-52. 2006
    ..It is also questionable whether the eventually selected women actually represent the general population of women with these disorders...
  23. ncbi The phenomenology of depressions and anxieties in women across different cultures. Guest editor's introduction to the special section
    Uriel Halbreich
    J Affect Disord 102:155-8. 2007
  24. ncbi Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes?
    Uriel Halbreich
    Biobehavior Research, State University of New York at Buffalo, Hayes Annex C Ste 1, 3435 Main Street, Buffalo, NY 14214, USA
    J Affect Disord 102:245-58. 2007
    ..Women also have a documented higher frequency of comorbid depression and anxiety disorders, and a three-fold higher prevalence of atypical depression...
  25. ncbi Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies
    Uriel Halbreich
    Departments of Psychiatry and Obstetrics and Gynecology, State University of New York at Buffalo, Buffalo, NY 14214, USA
    Gynecol Endocrinol 23:123-30. 2007
    ..It is also hoped that the proposed guidelines for quantification of criteria will be used by clinicians and investigators to facilitate diagnostic uniformity in the field as well as adequate treatment modalities when warranted...
  26. ncbi Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study
    Zerrin Emel Kayatekin
    Department of Psychiatry and Behavioral Sciences, Berkshire Medical Center, Pittsfield, MA 01201, USA
    Arch Womens Ment Health 11:207-11. 2008
    ..Anticonvulsant medications, specifically levetiracetam, could be effective in the treatment of PMDD. Future double-blind, placebo controlled, randomized studies are warranted and should include larger number of patients...
  27. ncbi Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation
    Uriel Halbreich
    Biobehavior Program, State University of New York at Buffalo, New York 14214, USA
    CNS Drugs 21:641-57. 2007
    ....
  28. ncbi Neurobehavioral impact of menopause on mood
    Jeanne Leventhal Alexander
    Kaiser Permanente Northern California, Psychiatry Women s Health Program, Oakland, CA, USA
    Expert Rev Neurother 7:S81-91. 2007
    ..In most cases, the period of vulnerability to mood problems subsides when the woman's hormonal levels stabilize and she enters full menopause...
  29. ncbi Participation in clinical trials may improve care of acute schizophrenia inpatients in a general hospital
    Uriel Halbreich
    Biobehavior Research, The State University of New York at Buffalo, Buffalo, NY, USA
    CNS Spectr 13:757-61. 2008
    ....
  30. ncbi Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough
    Uriel Halbreich
    Biobehavior Research, State University of New York at Buffalo, USA
    CNS Spectr 13:566-72. 2008
    ..There is a need to examine if this is actually the case. More recently, combined oral contraceptives (COCs) have been pursued due to their ovulation suppression effects. Their effects on PMS/PMDD should be further examined as well...
  31. ncbi Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptoms
    Uriel Halbreich
    Biobehavioral Program, State University of New York at Buffalo, Hayes Annex C, Ste 1, 3435 Main Street, 14214, USA
    J Affect Disord 91:97-111. 2006
    ..Most cited studies were conducted in Western economically developed countries...
  32. ncbi Major depression is not a diagnosis, it is a departure point to differential diagnosis -- clinical and hormonal considerations (a commentary and elaboration on Antonejevic's paper)
    Uriel Halbreich
    State University of New York at Buffalo, 3435 Main Street, Buffalo, NY 14214, USA
    Psychoneuroendocrinology 31:16-22; author reply 23-4. 2006
    ..Elucidation of the multiple underlying mechanisms of depressions and anxieties should lead to targeted treatment modalities and improvement of treatment responses...
  33. ncbi Bone mineral density and prolactin associations in patients with chronic schizophrenia
    George Abraham
    Department of Psychiatry, Medical College of Pennsylvania, Hahnemann University, 3300 Henry Avenue, Philadelphia, PA 19129, USA
    Schizophr Res 59:17-8. 2003
  34. ncbi Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices
    Mohamed F Mitwally
    Department of Gynecology and Obstetrics, State University of New Yorkat Buffalo, Buffalo, NY 14215, USA
    Expert Opin Pharmacother 3:1577-90. 2002
    ..The SSRIs are also efficacious when administered intermittently--only during the luteal phase of the menstrual cycle...
  35. ncbi Anxiety disorders in women: a developmental and lifecycle perspective
    Uriel Halbreich
    Department of Bio-Behavioral Research, State University of New York, Buffalo, NY, USA
    Depress Anxiety 17:107-10. 2003
  36. ncbi The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication
    Alan J Gelenberg
    University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    J Clin Psychiatry 65:1114-9. 2004
    ..A continuation study of an extract of St. John's wort (Hypericum perforatum) for depression was performed in follow-up to an acute study that found no significant difference between St. John's wort extract and placebo...
  37. ncbi Screening for mental illness in primary care clinics
    Linda S Kahn
    Department of Psychiatry, State University of New York at Buffalo School of Medicine, USA
    Int J Psychiatry Med 34:345-62. 2004
    ..A weakness of this study is that the POPR might generate false positive results. Even if this were the case, the rate of previous diagnoses was still extremely low...
  38. ncbi Algorithm for treatment of premenstrual syndromes (PMS): experts' recommendations and limitations
    Uriel Halbreich
    Biobehavior Program SUNY AB, Buffalo 14214, USA
    Gynecol Endocrinol 20:48-56. 2005
    ..The strengths as well as shortcomings of the experts' opinions processes are discussed. Substantial clinically-relevant research and assessments are still needed...
  39. ncbi Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries
    Lee S Cohen
    Perinatal Psychiatry Clinical Research Program, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    Obstet Gynecol 100:435-44. 2002
    ..To evaluate premenstrual daily dosing with fluoxetine for treatment of premenstrual dysphoric disorder...
  40. ncbi The association of perimenopausal mood disorders with other reproductive-related disorders
    Judith Feld
    Department of Psychiatry, State University of New York at Buffalo, Buffalo, NY, USA
    CNS Spectr 10:461-70. 2005
    ....
  41. ncbi Perimenopausal mental disorders: epidemiology and phenomenology
    Natalie Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Standord, CA 94305 5723, USA
    CNS Spectr 10:471-8. 2005
    ..At this time, more research is needed to address questions of prevalence, risk, and etiology for depression and other major mental disorders as related to the physiological and psychosocial changes associated with perimenopause...
  42. ncbi Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosis
    Jeanne Leventhal Alexander
    Kaiser Permanente Northern California, Psychiatry Women s Health Program, Oakland, CA, USA
    Expert Rev Neurother 7:S15-26. 2007
    ..Familiarity with the differential diagnosis, pathophysiology and evidence-based treatment for such patients is crucial to their proper care...
  43. ncbi Role of stressful life events and menopausal stage in wellbeing and health
    Jeanne Leventhal Alexander
    Psychiatry Women s Health Program, Kaiser Permanente Northern California, Oakland, CA, USA
    Expert Rev Neurother 7:S93-113. 2007
    ..Strategies for the optimal approach for clinicians to evaluate and treat the symptomatic perimenopausal patient with stressful life events and comorbid mood disorders are presented...
  44. ncbi Systematic reviews of clinical trials of acupuncture as treatment for depression: how systematic and accurate are they?
    Uriel Halbreich
    Biobehavior Research, State University of New York at Buffalo, Buffalo, NY, USA
    CNS Spectr 13:293-4, 299-300. 2008
  45. ncbi Postpartum disorders: multiple interacting underlying mechanisms and risk factors
    Uriel Halbreich
    J Affect Disord 88:1-7. 2005
  46. ncbi Mental symptoms and disorders during pregnancy
    Uriel Halbreich
    Biobehavioral Research Program, State University of New York at Buffalo, Buffalo, New York, USA
    CNS Spectr 9:176. 2004